Apixaban/clopidogrelSpinal subarachnoid haemorrhage due to combined off-label use of apixaban and clopidogrel: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1599卷 / 1期

关键词：

D O I：

10.1007/s40278-016-16891-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：28 / 28

相关论文

共 50 条

[31] RanibizumabSubconjunctival haemorrhage and off-label use: 4 case reports
Reactions Weekly, 2020, 1788 (1) : 200 - 200
[32] Enoxaparin sodium/methylprednisoloneCytomegalovirus reactivation, gastrointestinal haemorrhage and off-label use: case report
Reactions Weekly, 2020, 1831 (1) : 131 - 131
[33] ClopidogrelSpinal subarachnoid haemorrhage following inadvertent administration of drug: case report
Reactions Weekly, 2020, 1800 (1) : 104 - 104
[34] Apixaban/dabigatran etexilate/heparinIntracranial haemorrhage in the form of subarachnoid haemorrhage and subdural haemorrhage: 2 case reports
Reactions Weekly, 2022, 1912 (1) : 89 - 89
[35] PasireotideHyperglycaemia and off-label use: case report
Reactions Weekly, 2021, 1876 (1) : 273 - 273
[36] RituximabHypogammaglobulinaemia and off-label use: case report
Reactions Weekly, 2023, 1956 (1) : 453 - 453
[37] PosaconazoleHepatotoxicity and off-label use: case report
Reactions Weekly, 2024, 2021 (1) : 447 - 447
[38] ClozapineSyncope and off-label use: case report
Reactions Weekly, 2022, 1930 (1) : 198 - 198
[39] LinezolidLeukopenia and off-label use: case report
Reactions Weekly, 2025, 2044 (1) : 180 - 180
[40] IbrutinibNeutropenia and off-label use: case report
Reactions Weekly, 2020, 1787 (1) : 271 - 271

← 1 2 3 4 5 →